Solid biosciences to participate at upcoming investor conferences

Charlestown, mass., march 05, 2025 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company” or “solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:
SLDB Ratings Summary
SLDB Quant Ranking